Clinical Trial Update: QUILT-3.080: NANT Pancreatic Cancer Vaccine [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for QUILT-3.080 (NANT Pancreatic Cancer Vaccine) in pancreatic cancer; the Phase 1/2 study by ImmunityBio has been terminated and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• NANT Pancreatic Cancer Vaccine (QUILT-3.080)

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-08-27